SeaStar Medical Holding Corporation (ICU) News
Follow SeaStar Medical Holding Corporation (ICU) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
SeaStar Medical to Report Third-Quarter Results November 11
SeaStar Medical says it will report third-quarter financial results on November 11, 2026.
EQUITY | Nov 04, 2026, 01:42 PM UTC
L
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
Dr. Chung to deliver an oral presentation highlighting QUELIMMUNE®, an advanced extracorporeal therapy for critically ill pediatric patients with acute kidney injury (AKI)DENVER, Sept. 29, 2026 (GLOBE NEWSWIRE) -- SeaSta
NEWS | Sep 29, 2026, 12:38 PM UTC
L
SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
Prestigious honor recognizes Dr. Humes’ pioneering work in developing the Selective Cytopheretic Device (SCD) therapy, commercialized by SeaStar Medical as QUELIMMUNE® for critically ill pediatric patients with acute kid
NEWS | Sep 24, 2026, 12:21 PM UTC
L
ICU - SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
ICU - SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
NEWS | Sep 24, 2026, 12:16 PM UTC
L
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation NASDAQ:ICU, a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and
EQUITY | Sep 10, 2026, 12:42 PM UTC
L
ICU - SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
ICU - SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 10, 2026, 12:35 PM UTC
L
ICU Reports Q2 2026 Financial Results
ICU reports second quarter 2026 financial results and provides business updates
EARNINGS | Aug 12, 2026, 08:06 PM UTC
L
ICU - SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
ICU - SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
EARNINGS | Aug 06, 2026, 12:35 PM UTC
L
ICU Seastar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI) Sponsors Educational Summit of l
ICU Seastar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI) Sponsors Educational Summit of leading pediatric AKI health Care experts Announces best practices webinar to fur
EQUITY | Jul 14, 2026, 12:35 PM UTC
L
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Can Fite Biopharma (AMEX: CANF ) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ: RGC ) stock moved upwards by 35.79% t
EQUITY | Jul 01, 2026, 05:05 PM UTC
L
ICU: Announces New Codes
SeaStar Medical announces new ICD-10-PCS codes for its SCD therapy for acute kidney injury
EQUITY | Jun 23, 2026, 12:25 PM UTC